Summary
To evaluate possible influences of dietary intervention on the composition of very low-density lipoproteins (VLDL), ten subjects with Type 2 (non-insulin dependent) diabetes mellitus received a hypocaloric regimen. Fifteen healthy subjects served as controls. Ultracentrifuged VLDL were analysed as cholesterol, triglycerides, apolipoprotein B (apo B), and the soluble apolipoproteins C and E (polyacrylamide gel electrophoresis in urea and densitometry) before the study, after 2 weeks and then after 3 months. Compared with the control subjects, the content of cholesterol and apo E in the VLDL was elevated in the diabetic subjects, while the area ratio of apo C-II to apo C-III1 was lowered. After diet the reduction in VLDL was accompanied by compositional changes: a decrease of the cholesterol/triglyceride ratio and of the apo E/apo C area ratio. The apo C-II/apo C-III1 area ratio remained unaffected. We conclude that one beneficial effect of therapeutic intervention in diabetes may lie in lowering the level of possibly atherogenic VLDL-components.
Article PDF
Similar content being viewed by others
References
Garcia MJ, McNamara PM, Gordon T, Kannell WB (1974) Morbidity and mortality in diabetics in the Framingham population. Diabetes 23: 105–111
Wilson DE, Brown VW (1978) Lipids and lipoproteins in diabetes mellitus. In: Katzen HM, Mahler RJ (eds) Advances in modern nutrition 2, Part 1. Raven Press, New York, pp 127–186
Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH (1980) Hyperglycaemia and plasma lipid levels. A prospective study of young insulin-dependent diabetic patients. N Engl J Med 302: 650–654
Albrink MJ (1975) Dietary and drug treatment of hyperlipidaemia in diabetes. Diabetes 23: 913–918
Eisenberg S (1979) Very low-density lipoprotein metabolism. Prog Biochem Pharmacol 15: 139–165
Ganesan D, Bass HB, McConathy WJ, Alaupovic P (1976) Is decreased activity of C-II activated lipoprotein lipase in Type III hyperlipoproteinaemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels? Metabolism 25: 1189–1195
Innerarity TL, Mahley RW (1978) Enhanced binding by cultured human fibroblasts of apo E-containing lipoproteins as compared with low-density lipoproteins. Biochemistry 17: 1440–1447
Schonfeld G, Birge L, Miller JP, Kessler G, Santiago J (1974) Apoprotein B levels and altered lipoprotein composition in diabetes. Diabetes 23: 827–834
Gabor J, Spain M, Kalant N (1980) Composition of serum very low-density and high-density lipoproteins in diabetes. Clin Chem 26: 1261–1265
Schwandt P, Weisweiler P (1980) The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary Type IIa hyperlipoproteinaemia. Atherosclerosis 35: 301–306
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Kane JP (1973) A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins. Anal Biochem 53: 350–364
Lisch HJ, Sailer S (1981) Lipoprotein patterns in diet, sulphonurea, and insulin-treated diabetics. Diabetologia 20: 118–122
Taskinen MR, Nikkilä EA (1979) Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Diabetologia 17: 351–356
Lopes-Virella MFL, Stone PG, Colwell JA (1977) Serum highdensity lipoproteins in diabetic patients. Diabetologia 13: 285–291
Taylor KG, Wright AD. Carter TJN, Valente AJ, Betts SA, Matthews KA (1981) High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes. Diabetologia 20: 535–539
Schwandt P, Weisweiler P (1981) High-density lipoprotein subfractions after a short-term fast. Horm Metab Res 13: 467–468
Weisweiler P, Drosner M, Janetschek P, Schwandt P (1981) Lipid- und Apolipoproteingehalt von Lipoproteinen sehr niedriger Dichte (VLDL) unter einer fettmodifizierten Diät. Verh Dtsch Ges Inn Med 87: 976–978
Pagnan A, Casam D, Zanetti G, Guarini P, Braggion M (1980) Serum lipids, double pre-beta lipoproteinaemia, and distribution of the apo very low-density lipoprotein (VLDL) peptides in hypothyroid patients before and after substitution therapy. Metabolism 29: 1026–1030
Bierman EL, Stein O, Stein Y (1974) Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ Res 35: 136–150
Goldstein JL, Ho YK, Brown MS, Innerarity TL, Mahley RW (1980) Cholesteryl ester accumulation in macrophages resulting from receptor mediated uptake and degradation of hypercholesterolaemia canineβ-very low-density lipoproteins. J Biol Chem 255: 1839–1848
Pagnan A, Havel RJ, Kane JP, Kotite L (1977) Characterization of human very low-density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinaemia and primary dyslipoproteinaemia. J Lipid Res 18: 613–622
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weisweiler, P., Drosner, M. & Schwandt, P. Dietary effects on very low-density lipoproteins in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 23, 101–103 (1982). https://doi.org/10.1007/BF01271168
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01271168